Advertisement

Topics

Abbott's third-quarter earnings edge past Street

05:30 EDT 19 Oct 2016 | Reuters

(Reuters) - Abbott Laboratories, which is acquiring St. Jude Medical Inc for $25 billion, reported a quarterly profit that edged past estimates as strength in its medical devices business more than offset a decline in its nutrition unit.

Original Article: Abbott's third-quarter earnings edge past Street

NEXT ARTICLE

More From BioPortfolio on "Abbott's third-quarter earnings edge past Street"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...